Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,138 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200.7B 1769 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| Q QuartzBioCompany profile Provides AI-powered sample and biomarker intelligence platform for clinical-stage biopharma Provides AI-powered sample and biomarker intelligence platform for clinical-stage biopharma | Undisclosed | Growth | Healthtech | United States | Investors | |
| 9 9amHealthCompany profile AI-enabled virtual specialty care platform for managing high-cost chronic conditions AI-enabled virtual specialty care platform for managing high-cost chronic conditions | $26M | Series B | Healthtech | United States | Investors | |
| MR Mind RoboticsCompany profile Builds full-stack AI-enabled industrial robotics platform to automate dexterous manufacturing tasks at scale Builds full-stack AI-enabled industrial robotics platform to automate dexterous manufacturing tasks at scale | $400M | Series B | Robotics | United States | Investors | |
| AI Anomaly InsightsCompany profile Analyzes healthcare transactions in real time to identify payer behavior patterns and recover provider revenue Analyzes healthcare transactions in real time to identify payer behavior patterns and recover provider revenue | $17M | Series B | Healthtech | United States | Investors | |
| OL Origin LabCompany profile Turns licensed video game worlds into structured training data for world models and multimodal AI Turns licensed video game worlds into structured training data for world models and multimodal AI | $8M | Seed | AI | United States | Investors | |
 Autoimmunity BioSolutionsCompany profile Genetically guided therapies targeting elevated soluble IL7 receptor levels in autoimmune disease. Genetically guided therapies targeting elevated soluble IL7 receptor levels in autoimmune disease. | $1M | Seed extensionSeed | Biotech | United States | Investors | |
| B BranchLabCompany profile Builds AI platform helping pharma companies identify, activate and optimize patient and HCP audiences Builds AI platform helping pharma companies identify, activate and optimize patient and HCP audiences | $26M | Series A | Healthtech | United States | Investors | |
 CasimirCompany profile Casimir is developing semiconductor chips intended to supply power without conventional batteries. Casimir is developing semiconductor chips intended to supply power without conventional batteries. | $12M | Seed | Hardware | United States | Investors | |
 ForusCompany profile Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows. Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows. | $160M | Series A | Healthtech | United States | Investors | |
| FE Fervo EnergyCompany profile Fervo Energy develops geothermal power projects using horizontal drilling and subsurface monitoring. Fervo Energy develops geothermal power projects using horizontal drilling and subsurface monitoring. | $2.2B | IPO including full over-allotmentGrowth | Climate tech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
126rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Ocular AI, Mona
56rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.